- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07842913
Hybrid Telerehabilitation for Anterior Knee Pain in Routine Physiotherapy Practice
Integrating Hybrid Telerehabilitation Into Routine Physiotherapy Practice for Anterior Knee Pain: Protocol for a Real-World Pragmatic Mixed-Methods Study
This study will examine how hybrid telerehabilitation is used in routine physiotherapy care for adults with anterior knee pain. Approximately 30 participants will be followed for 72 weeks while receiving individualized treatment from their physiotherapist, supported by the moveUP mobile application. The application provides prescribed exercises, educational information, communication with the physiotherapist, and progress monitoring.
The study will assess adherence to rehabilitation, pain, knee function, quality of life, psychological factors, and physical activity. It will also explore whether patient adherence and physiotherapist engagement are associated with clinical outcomes. Interviews with patients and healthcare professionals will examine barriers and facilitators to using the platform in routine care.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Miguel Farraj, PhD candidate
- Número de teléfono: +32494035113
- Correo electrónico: miguel.farraj@ulb.be
Ubicaciones de estudio
-
-
-
Brussels, Bélgica
- Reclutamiento
- Private clinics
-
Contacto:
- Miguel Farraj, PhD candidate
- Número de teléfono: +32494035113
- Correo electrónico: miguel.farraj@ulb.be
-
-
-
-
-
Paris, Francia
- Reclutamiento
- Private clinics
-
Contacto:
- Miguel Farraj, PhD candidate
- Número de teléfono: +32494035113
- Correo electrónico: miguel.farraj@ulb.be
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Age 18 years or older.
- Clinical diagnosis of anterior knee pain, including patellofemoral pain, patellar tendinopathy, Hoffa's fat pad syndrome, chondromalacia, or femoropatellar, tibiopatellar, or tibiofemoral osteoarthritis not requiring surgery.
- Access to a smartphone compatible with the moveUP application.
Exclusion Criteria:
- Currently awaiting spine or lower-limb surgery.
- Lower-limb surgery or other invasive intervention within the previous two years.
- Joint prosthesis.
- Acute trauma to the trunk or lower limbs, or fracture, dislocation, or other musculoskeletal pathology of the affected lower limb within the previous six months.
- Saphenous nerve neuritis or Ehlers-Danlos syndrome.
- Severe osteoarthritis requiring joint replacement, systemic inflammatory joint disease (including rheumatoid arthritis or gout), or joint infection.
- Persistent low back pain lasting three months or longer.
- Vascular, respiratory, or neurological conditions that interfere with participation.
- Cognitive or psychiatric impairment limiting application use or communication.
- Pregnancy.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Hybrid Telerehabilitation
Participants receive individualized physiotherapy for anterior knee pain supported by the moveUP mobile application over 72 weeks. Treatment is prescribed and adapted by the treating physiotherapist according to individual patient needs. |
Hybrid telerehabilitation combining routine physiotherapy with the moveUP mobile application for adults with anterior knee pain. The platform supports individualized exercise prescription, educational modules, patient-physiotherapist communication, and progress monitoring. Exercise selection, frequency, and progression are determined by the treating physiotherapist according to patient needs. Participants are followed for 72 weeks. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Exercise Adherence (ATEMPT Score)
Periodo de tiempo: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Exercise adherence will be assessed using the Adherence to Exercise for Musculoskeletal Pain Tool (ATEMPT). Total scores range from 6 to 30, with higher scores indicating greater adherence. |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Pain Intensity (Visual Analog Scale)
Periodo de tiempo: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Pain intensity will be measured using a 0-100 mm Visual Analog Scale (VAS), where 0 indicates no pain and 100 indicates the worst pain imaginable. Higher scores indicate greater pain intensity. |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Knee Function (Anterior Knee Pain Scale)
Periodo de tiempo: aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
The Anterior Knee Pain Scale assesses symptoms and functional limitations associated with anterior knee pain. The total score ranges from 0 to 100, with higher scores indicating better function and fewer symptoms |
aseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Health-Related Quality of Life (EQ-5D)
Periodo de tiempo: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
Health-related quality of life will be assessed using the EuroQol 5-Dimension 5-Level (EQ-5D-5L) questionnaire. Responses will be converted into a utility index using the Belgian value set. Scores range from -0.532 to 1, with higher scores indicating better health-related quality of life. |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Fear of Movement (Tampa Scale for Kinesiophobia)
Periodo de tiempo: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
The 11-item Tampa Scale for Kinesiophobia assesses fear of movement or reinjury. The total score ranges from 11 to 44, with higher scores indicating greater kinesiophobia and therefore a worse outcome |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Pain Catastrophizing (Pain Catastrophizing Scale)
Periodo de tiempo: Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
The Pain Catastrophizing Scale is a 13-item questionnaire assessing catastrophic thoughts related to pain. The total score ranges from 0 to 52, with higher scores indicating greater pain catastrophizing and therefore a worse outcome |
Baseline and weeks 6, 12, 18, 24, 36, 48, 60, and 72
|
|
Physical Activity (Daily Step Count)
Periodo de tiempo: Daily/weekly
|
Daily/weekly
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- AIM2-AKP-001
- 2024-RDIR-5c (Otro número de subvención/financiamiento: Innoviris)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .